A detailed history of Fred Alger Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Fred Alger Management, LLC holds 102,293 shares of BMY stock, worth $5.86 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
102,293
Previous 41,496 146.51%
Holding current value
$5.86 Million
Previous $1.72 Million 207.2%
% of portfolio
0.03%
Previous 0.01%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $2.41 Million - $3.15 Million
60,797 Added 146.51%
102,293 $5.29 Million
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $149,971 - $197,440
3,726 Added 9.86%
41,496 $1.72 Million
Q1 2024

May 15, 2024

SELL
$47.98 - $54.4 $132,424 - $150,144
-2,760 Reduced 6.81%
37,770 $2.05 Million
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $14,786 - $17,644
305 Added 0.76%
40,530 $2.08 Million
Q1 2023

May 15, 2023

BUY
$65.71 - $74.53 $102,179 - $115,894
1,555 Added 4.02%
40,225 $2.79 Million
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $261,182 - $309,277
3,814 Added 10.94%
38,670 $2.78 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $12,963 - $7.66 Million
-99,723 Reduced 74.1%
34,856 $2.48 Million
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $1.92 Million - $2.12 Million
-26,488 Reduced 16.45%
134,579 $10.4 Million
Q1 2022

May 16, 2022

BUY
$61.48 - $73.72 $2.01 Million - $2.41 Million
32,645 Added 25.42%
161,067 $11.8 Million
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $5.17 Million - $6.03 Million
96,493 Added 302.21%
128,422 $8.01 Million
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $14,910 - $17,466
-252 Reduced 0.78%
31,929 $1.89 Million
Q1 2021

May 17, 2021

SELL
$59.34 - $66.74 $1.24 Million - $1.4 Million
-20,924 Reduced 39.4%
32,181 $2.03 Million
Q4 2020

Feb 16, 2021

BUY
$57.74 - $65.43 $1.21 Million - $1.37 Million
20,924 Added 65.02%
53,105 $3.29 Million
Q2 2020

Aug 14, 2020

SELL
$54.82 - $64.09 $14.9 Million - $17.4 Million
-271,931 Reduced 89.42%
32,181 $1.89 Million
Q1 2020

May 15, 2020

BUY
$46.4 - $67.43 $11.3 Million - $16.5 Million
244,452 Added 409.74%
304,112 $17 Million
Q4 2019

Feb 14, 2020

SELL
$49.21 - $64.19 $89,119 - $116,248
-1,811 Reduced 2.95%
59,660 $3.83 Million
Q3 2019

Nov 14, 2019

BUY
$42.77 - $50.71 $1.44 Million - $1.7 Million
33,556 Added 120.21%
61,471 $3.12 Million
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $18,204 - $20,130
-408 Reduced 1.44%
27,915 $1.27 Million
Q1 2019

May 14, 2019

SELL
$45.12 - $53.8 $8.24 Million - $9.83 Million
-182,718 Reduced 86.58%
28,323 $1.35 Million
Q4 2018

Feb 14, 2019

SELL
$48.76 - $63.23 $24.4 Million - $31.6 Million
-499,840 Reduced 70.31%
211,041 $11 Million
Q3 2018

Nov 14, 2018

SELL
$55.19 - $62.25 $518,178 - $584,465
-9,389 Reduced 1.3%
710,881 $44.1 Million
Q2 2018

Jul 19, 2018

SELL
$50.53 - $62.98 $48.1 Million - $60 Million
-951,896 Reduced 56.93%
720,270 $39.9 Million
Q1 2018

May 10, 2018

BUY
$59.92 - $68.98 $18.5 Million - $21.3 Million
308,629 Added 22.63%
1,672,166 $106 Million
Q4 2017

Feb 14, 2018

BUY
$59.94 - $65.35 $24.4 Million - $26.6 Million
406,966 Added 42.54%
1,363,537 $83.6 Million
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $52.8 Million - $61 Million
956,571
956,571 $61 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.